News
Bayer decides to withdraw cholesterol lowering drug
BMJ 2001; 323 doi: https://doi.org/10.1136/bmj.323.7309.359/a (Published 18 August 2001) Cite this as: BMJ 2001;323:359
- Fred Charatan
- Florida
Cerivastatin (Baycol in the United States, Lipobay in the United Kingdom), a cholesterol lowering drug made by Bayer Corporation and initially approved in the US in 1997, has been withdrawn by the manufacturer. There have been 31 deaths in the US from severe rhabdomyolysis in patients taking the drug. Twelve patients were taking concomitant gemfibrozil, which lowers blood concentration of triglycerides.
Rhabdomyolysis, a serious and potentially fatal adverse effect of …
Log in
Log in using your username and password
Log in through your institution
Subscribe from £173 *
Subscribe and get access to all BMJ articles, and much more.
* For online subscription
Access this article for 1 day for:
£38 / $45 / €42 (excludes VAT)
You can download a PDF version for your personal record.